New research has uncovered a key reason why many people experience muscle pain and weakness while taking statins. Using advanced imaging, scientists found that statins can latch onto a calcium-regulating channel inside muscle cells and force it open. This causes a constant leak of calcium, which stresses and damages muscle tissue. While serious injury is rare, millions of patients deal with milder symptoms that often lead them to stop the medication.
The study showed that statins bind to this calcium channel in a tight, clustered way that pushes it into an overactive state. This mechanism appears to apply across the entire drug class — not just one brand or dose. The findings provide the first clear structural evidence explaining how statins interfere with muscle function, giving scientific support to what many patients have reported for years. It also identifies a biochemical pathway that drug developers can now target.
Researchers believe future versions of statins could be redesigned to avoid this muscle-protein interaction while still lowering cholesterol. That could mean fewer aches, less fatigue and better long-term adherence for patients who depend on these drugs. The results also highlight the importance of studying how common medications affect cellular energy and muscle health. With redesigned statins, treatment could become safer and more comfortable for the millions who rely on them.
SOURCE: